Contrast-induced acute kidney injury (CIAKI) occurs in up to 30% of patients who receive
iodinated contrast media and is generally considered to be the third most common cause of …

Interstitial fibrosis is the common endpoint of end-stage chronic kidney disease (CKD)
leading to kidney failure. The clinical course of many renal diseases, and thereby of CKD, is …

Over the last decade, significant progress has been made in the identification and validation
of novel biomarkers as well as refinements in the use of serum creatinine as a marker of …

Iodinated contrast media (ICM) induced acute kidney injury (AKI) accounts for 11% of cases
of AKI and is its third most common cause in hospitalized patients. However, the …

Acute kidney injury (AKI) is associated with prolonged hospitalization and high mortality, and
it predisposes individuals to chronic kidney disease. To date, no effective AKI treatments …

Acute kidney injury (AKI) following platinum-based chemotherapeutics is a frequently
reported serious side-effect. However, there are no approved biomarkers that can properly …

KIM-1 (kidney injury molecule 1) is a transmembrane glycoprotein also known as HAVcr-1
and TIM-1 belongs to the T-cell immunoglobulin and mucin domain family (TIM) of proteins …

Background Diabetic kidney disease (DKD) stands as a primary contributor to end-stage
renal disease, associated with heightened mortality in cardiovascular diseases. This study …

Abstract Kidney injury molecule-1 (KIM-1), a type l transmembrane glycoprotein, is
recognized as a potential biomarker for detection of tubular injury in the main renal …

Diabetic kidney disease (DKD) is a serious complication of diabetes that can lead to end-
stage kidney disease. Despite its significant impact, most research has concentrated on the …